OLBA HEALTHCARE HOLDINGS, Inc.

TSE:2689 Stock Report

Market Cap: JP¥12.0b

OLBA HEALTHCARE HOLDINGS Past Earnings Performance

Past criteria checks 4/6

OLBA HEALTHCARE HOLDINGS has been growing earnings at an average annual rate of 21%, while the Healthcare industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 1.4% per year. OLBA HEALTHCARE HOLDINGS's return on equity is 13.6%, and it has net margins of 1.2%.

Key information

21.0%

Earnings growth rate

20.3%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate1.4%
Return on equity13.6%
Net Margin1.2%
Next Earnings Update31 Jan 2025

Recent past performance updates

Recent updates

With EPS Growth And More, OLBA HEALTHCARE HOLDINGS (TSE:2689) Makes An Interesting Case

Aug 06
With EPS Growth And More, OLBA HEALTHCARE HOLDINGS (TSE:2689) Makes An Interesting Case

OLBA HEALTHCARE HOLDINGS (TSE:2689) Is Due To Pay A Dividend Of ¥70.00

Jun 07
OLBA HEALTHCARE HOLDINGS (TSE:2689) Is Due To Pay A Dividend Of ¥70.00

OLBA HEALTHCARE HOLDINGS (TSE:2689) Is Due To Pay A Dividend Of ¥70.00

Apr 25
OLBA HEALTHCARE HOLDINGS (TSE:2689) Is Due To Pay A Dividend Of ¥70.00

Revenue & Expenses Breakdown

How OLBA HEALTHCARE HOLDINGS makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

TSE:2689 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24120,1121,50011,5580
30 Jun 24118,5641,50011,3740
31 Mar 24117,0221,49611,2930
31 Dec 23114,2201,35311,1650
30 Sep 23111,6601,33110,9790
30 Jun 23110,4721,41410,8100
31 Mar 23109,0551,43510,7910
31 Dec 22108,6471,55010,6340
30 Sep 22109,2531,61110,4980
30 Jun 22107,9591,53510,4300
31 Mar 22108,8041,23910,1940
31 Dec 21110,7241,13210,1640
30 Sep 21111,8801,11010,1060
30 Jun 21112,97698910,0580
31 Mar 21109,8847509,9370
31 Dec 20107,6315469,8920
30 Sep 20105,65113710,1620
30 Jun 20107,89632610,1400
31 Mar 20110,13162810,1760
31 Dec 19108,59457310,1730
30 Sep 19111,0101,0259,8330
30 Jun 19107,4287759,8350
31 Mar 19106,2906799,9000
31 Dec 18107,4818309,8980
30 Sep 18106,2088439,8640
30 Jun 18107,6631,0549,7870
31 Mar 18107,2831,0109,8070
31 Dec 17107,1579089,7860
30 Sep 17106,5468749,8090
30 Jun 17105,7786909,8540
31 Mar 17104,9166689,6980
31 Dec 16105,4065919,6560
30 Sep 16103,8163979,6230
30 Jun 16101,4603059,5920
31 Mar 16101,1774419,4330
31 Dec 1598,1083819,3640
30 Sep 1595,1503209,2490
30 Jun 1594,5154059,0900
31 Mar 1591,0892129,0820
31 Dec 1494,8255518,9590
30 Sep 1495,6996128,8230
30 Jun 1497,1378168,6800
31 Mar 1499,9428848,7570
31 Dec 1397,7558538,6840

Quality Earnings: 2689 has high quality earnings.

Growing Profit Margin: 2689's current net profit margins (1.2%) are higher than last year (1.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 2689's earnings have grown significantly by 21% per year over the past 5 years.

Accelerating Growth: 2689's earnings growth over the past year (12.7%) is below its 5-year average (21% per year).

Earnings vs Industry: 2689 earnings growth over the past year (12.7%) exceeded the Healthcare industry 8.3%.

Return on Equity

High ROE: 2689's Return on Equity (13.6%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 19:07
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

OLBA HEALTHCARE HOLDINGS, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Takashi AkahaneTokai Tokyo Intelligence Laboratory Co., Ltd.